Navigation Links
Low grade prostate cancer may be treated with mild treatment

In the Journal of American Medical Association, a recent study had shown that //low-grade prostate cancer has a very less risk of developing in next 20 years.

Scientists have treated men in the age of to 74 years who were diagnosed with clinically localized prostate cancer conservatively. They have used either observation or immediate or delayed androgen withdrawal therapy. The patients were observed for a mean period of 24 years.

The results of the study had shown that patients with low-grade prostate cancer had very less of cancer progressing in 20 years under observation or treatment by androgen withdrawal therapy alone. The risk of death from low-grade prostate cancer seems to be 0.6% only for each year.

A low-grade prostate cancer is the one, which can be given a rating of 2 to 4 in the Gleason scale. In the poorly differentiated disease which has a Gleason score of 7 to 10, the risk of death increases to about 12.1% for people diagnosed with prostate cancer and dying within 10 years of dying.

The researchers are of the opinion that patients diagnosed with low-grade prostate cancer, thus, should not be treated aggressively medically as the disease can be controlled otherwise. , low-grade prostate cancer, Gleason score, less risk of developing, androgen withdrawal therapy, poorly differentiated disease
'"/>




Page: 1

Related medicine news :

1. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
2. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
3. Kottayam Medical College To be Upgraded
4. Government May Downgrade Cannabis
5. Health Grade, grades U.S Hospitals
6. Upgrade Health Benefits: Wal-Mart in a Tight Spot
7. QIO to Be Upgraded
8. Academics Question Veracity Of NHS IT Upgrade Plan
9. India to Upgrade 13 Medical Institutions to Provide Quality Medical Education
10. Low grade for Canada in Primary Health care
11. Rohini Forensic Lab to Be Upgraded
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: